Search details
1.
Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations.
BJU Int
; 2024 Feb 25.
Article
in English
| MEDLINE | ID: mdl-38403809
2.
Plasma Levels of Pentraxin 3: A Potential Prognostic Biomarker in Urinary Bladder Cancer Patients.
Int J Mol Sci
; 25(6)2024 Mar 20.
Article
in English
| MEDLINE | ID: mdl-38542446
3.
Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study.
Acta Oncol
; 61(8): 922-930, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35881046
4.
Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe).
BJU Int
; 126(5): 625-632, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32762064
5.
No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study.
World J Urol
; 38(2): 381-388, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31020424
6.
Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care: a nationwide population-based study.
BJU Int
; 124(3): 449-456, 2019 09.
Article
in English
| MEDLINE | ID: mdl-30950568
7.
[Radical cystectomy for bladder cancer is a complex procedure]. / Cystektomi för blåscancer har utfallet förbättrats?
Lakartidningen
; 1212024 01 31.
Article
in Swedish
| MEDLINE | ID: mdl-38343316
8.
Cystectomy for bladder cancer in Sweden - short-term outcomes after centralization.
Scand J Urol
; 59: 84-89, 2024 Apr 29.
Article
in English
| MEDLINE | ID: mdl-38685576
9.
Diagnostic pathways and treatment strategies in upper tract urothelial carcinoma in Sweden between 2015 and 2021: a population-based survey.
Scand J Urol
; 59: 19-25, 2024 Jan 16.
Article
in English
| MEDLINE | ID: mdl-38226846
10.
Diagnostic value of repeated comprehensive investigation with CT urography and cystoscopy for recurrent macroscopic haematuria.
BJUI Compass
; 5(2): 253-260, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38371208
11.
Health-related quality of life prior to and 1 year after radical cystectomy evaluated with FACT-G and FACT-VCI questionnaires.
Scand J Urol
; 58: 76-83, 2023 Sep 21.
Article
in English
| MEDLINE | ID: mdl-37747157
12.
Short term outcomes after robot assisted and open cystectomy - A nation-wide population-based study.
Eur J Surg Oncol
; 49(4): 868-874, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36759262
13.
Preoperative upper tract invasive diagnostic modalities are associated with intravesical recurrence following surgery for upper tract urothelial carcinoma: A population-based study.
PLoS One
; 18(2): e0281304, 2023.
Article
in English
| MEDLINE | ID: mdl-36730353
14.
Standardized care pathways for patients with suspected urinary bladder cancer: the Swedish experience.
Scand J Urol
; 56(3): 227-232, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35389306
15.
Number of transurethral procedures after non-muscle-invasive bladder cancer and survival in causes other than bladder cancer.
PLoS One
; 17(9): e0274859, 2022.
Article
in English
| MEDLINE | ID: mdl-36149914
16.
Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0.
BMJ Open
; 12(12): e064898, 2022 12 20.
Article
in English
| MEDLINE | ID: mdl-36600418
17.
Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999: a population-based study.
Scand J Urol
; 56(1): 14-18, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34623216
18.
Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer.
Scand J Urol
; 56(1): 27-33, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34775873
19.
Swedish National Guidelines on Urothelial Carcinoma: 2021 update on non-muscle invasive bladder cancer and upper tract urothelial carcinoma.
Scand J Urol
; 56(2): 137-146, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35225148
20.
Soluble PD-L1 in Serum and Urine in Urinary Bladder Cancer Patients.
Cancers (Basel)
; 13(22)2021 Nov 21.
Article
in English
| MEDLINE | ID: mdl-34830993